BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10821536)

  • 1. Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells.
    Portella G; Vitagliano D; Borselli C; Melillo RM; Salvatore D; Rothstein JL; Vecchio G; Fusco A; Santoro M
    Oncol Res; 1999; 11(9):421-7. PubMed ID: 10821536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line.
    Santoro M; Melillo RM; Grieco M; Berlingieri MT; Vecchio G; Fusco A
    Cell Growth Differ; 1993 Feb; 4(2):77-84. PubMed ID: 8494786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
    Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
    Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TPA induces a block of differentiation and increases the susceptibility to neoplastic transformation of a rat thyroid epithelial cell line.
    Portella G; Vitagliano D; Li Z; Sferratore F; Santoro M; Vecchio G; Fusco A
    Oncol Res; 1998; 10(9):441-7. PubMed ID: 10223619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells.
    Ivan M; Bond JA; Prat M; Comoglio PM; Wynford-Thomas D
    Oncogene; 1997 May; 14(20):2417-23. PubMed ID: 9188856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAS oncogene activation induces proliferation in normal human thyroid epithelial cells without loss of differentiation.
    Gire V; Wynford-Thomas D
    Oncogene; 2000 Feb; 19(6):737-44. PubMed ID: 10698491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Adenovirus E1A gene blocks the differentiation of a thyroid epithelial cell line, however the neoplastic phenotype is achieved only after cooperation with other oncogenes.
    Berlingieri MT; Santoro M; Battaglia C; Grieco M; Fusco A
    Oncogene; 1993 Feb; 8(2):249-55. PubMed ID: 8426735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutated human Kirsten ras, driven by a thyroglobulin promoter, induces a growth advantage and partially dedifferentiates rat thyroid epithelial cells in vitro.
    Monaco C; Califano D; Chiappetta G; Mineo A; De Franciscis V; Vecchio G; Santelli G
    Int J Cancer; 1995 Nov; 63(5):757-60. PubMed ID: 7591297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant ras-induced proliferation of human thyroid epithelial cells requires three effector pathways.
    Bounacer A; McGregor A; Skinner J; Bond J; Poghosyan Z; Wynford-Thomas D
    Oncogene; 2004 Oct; 23(47):7839-45. PubMed ID: 15361839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-ras oncogene interferes with the expression of cyclic AMP-dependent promoters.
    Gallo A; Feliciello A; Varrone A; Cerillo R; Gottesman ME; Avvedimento VE
    Cell Growth Differ; 1995 Jan; 6(1):91-5. PubMed ID: 7718489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene.
    Lemoine NR; Staddon S; Bond J; Wyllie FS; Shaw JJ; Wynford-Thomas D
    Oncogene; 1990 Dec; 5(12):1833-7. PubMed ID: 1704496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter.
    Rochefort P; Caillou B; Michiels FM; Ledent C; Talbot M; Schlumberger M; Lavelle F; Monier R; Feunteun J
    Oncogene; 1996 Jan; 12(1):111-8. PubMed ID: 8552381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid cell transformation requires the expression of the HMGA1 proteins.
    Berlingieri MT; Pierantoni GM; Giancotti V; Santoro M; Fusco A
    Oncogene; 2002 May; 21(19):2971-80. PubMed ID: 12082527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forskolin and a tumor promoter are able to induce c-fos and c-myc expression in normal, but not in a v-ras-transformed rat thyroid cell line.
    Colletta G; Cirafici AM; Consiglio E; Vecchio G
    Oncogene Res; 1987; 1(4):459-66. PubMed ID: 3329719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
    Shimura H; Suzuki H; Miyazaki A; Furuya F; Ohta K; Haraguchi K; Endo T; Onaya T
    Cancer Res; 2001 May; 61(9):3640-6. PubMed ID: 11325833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple mechanisms of interference between transformation and differentiation in thyroid cells.
    Francis-Lang H; Zannini M; De Felice M; Berlingieri MT; Fusco A; Di Lauro R
    Mol Cell Biol; 1992 Dec; 12(12):5793-800. PubMed ID: 1448106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The v-erbA oncogene selectively inhibits iodide uptake in rat thyroid cells.
    Trapasso F; Martelli ML; Battaglia C; Angotti E; Mele E; Stella A; Samarut J; Avvedimento VE; Fusco A
    Oncogene; 1996 May; 12(9):1879-88. PubMed ID: 8649848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoter.
    Santelli G; de Franciscis V; Portella G; Chiappetta G; D'Alessio A; Califano D; Rosati R; Mineo A; Monaco C; Manzo G
    Cancer Res; 1993 Nov; 53(22):5523-7. PubMed ID: 8221693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiation.
    Cass LA; Meinkoth JL
    Oncogene; 2000 Feb; 19(7):924-32. PubMed ID: 10702801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 genes mutated in the DNA binding site or at a specific COOH-terminal site exert divergent effects on thyroid cell growth and differentiation.
    Casamassimi A; Miano MG; Porcellini A; De Vita G; de Nigris F; Zannini M; Di Lauro R; Russo T; Avvedimento VE; Fusco A
    Cancer Res; 1998 Jul; 58(13):2888-94. PubMed ID: 9661907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.